|
Volumn , Issue , 2013, Pages
|
Endocrine resistance: what do we know?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE INHIBITOR;
CYCLIN DEPENDENT KINASE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
ESTROGEN;
ESTROGEN RECEPTOR;
GROWTH FACTOR RECEPTOR;
PROGESTERONE;
PROGESTERONE RECEPTOR;
PROTEIN KINASE INHIBITOR;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SIGNAL PEPTIDE;
TUMOR PROTEIN;
BREAST NEOPLASMS;
CELL CYCLE;
DRUG EFFECTS;
DRUG RESISTANCE;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
NEOPLASMS, HORMONE-DEPENDENT;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
CELL CYCLE;
CYCLIN-DEPENDENT KINASES;
DRUG RESISTANCE, NEOPLASM;
ESTROGEN RECEPTOR MODULATORS;
ESTROGENS;
FEMALE;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;
NEOPLASM PROTEINS;
NEOPLASMS, HORMONE-DEPENDENT;
PROGESTERONE;
PROTEIN KINASE INHIBITORS;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
RECEPTORS, GROWTH FACTOR;
RECEPTORS, PROGESTERONE;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
SIGNAL TRANSDUCTION;
|
EID: 84952360331
PISSN: None
EISSN: 15488756
Source Type: Journal
DOI: 10.1200/EdBook_AM.2013.33.e37 Document Type: Review |
Times cited : (15)
|
References (0)
|